Myeloma Center

The Myeloma Center at New York Presbyterian – Weill Cornell Medical Center is a comprehensive program for the treatment of multiple myeloma and related plasma cell diseases. Our focus is on providing cutting edge medical technologies and the latest in myeloma treatment personalized to each patient.

News

December 14, 2018
Each year, the American Society of Hematology (ASH) Annual Meeting and Exposition convenes over 25,000 clinicians and scientists from around the world to discuss the latest...
August 14, 2018
Tour Our New Home
The Weill Cornell Medicine Myeloma Center's new home on 425 E 61st Street features semi-private infusion spaces, a dedicated social worker, and more! Join the Center's Director,...
February 20, 2018
Drs. Rossi and Monge standing at a podium.
The national Multiple Myeloma Rounds Program was established in 2016 to provide a forum for local healthcare professionals to address specific issues related to the diagnosis and treatment of multiple myeloma patients. At the recent CME-accredited Multiple Myeloma Rounds Program in New York City, several key opinion leaders and subject matter experts were invited to speak about topics related to myeloma patient care and treatment.

In May 2018, the Myeloma Center moved to 425 E. 61st St – 8th Floor. Learn more about this location.

For Patients

Make an appointment, prepare for your first visit, and access our health information library, complete with resources on frequently asked questions, our ongoing support groups and the latest research and treatments.

Find out more about patient care

Research and Clinical Trials

Research and clinical trials are critical to developing new treatments and cures for myeloma, amyloidosis and related plasma cell disorders. Learn about our world-class research program which offers Myeloma Center patients access to the newest therapies.

Find out more about research

Our Team

Meet our healthcare team and learn about our approach to care. We have many years of expertise in providing outstanding clinical care in the treatment of multiple myeloma, amyloidosis and other plasma cell disorders.

View All Team Members